Cocaine Use in Pregnancy and Neonatal Outcomes

Cocaine use during pregnancy poses severe risks to both the mother and the developing fetus. The drug can cross the placenta, disrupting fetal blood flow and oxygenation, leading to complications such as low birth weight, preterm labor, and placental abruption. Neonates exposed to cocaine in utero often face withdrawal symptoms, irritability, and feeding difficulties. Additionally, there are long-term neurodevelopmental challenges, including deficits in attention, memory, and behavior. Addressing this issue involves integrating addiction treatment with prenatal care to ensure better maternal and neonatal outcomes. Multidisciplinary approaches, including counseling, social support, and medical monitoring, are essential to mitigate risks. Early intervention programs post-birth can help infants overcome developmental delays while equipping mothers with tools for sustained recovery and effective parenting.